1.Impact of Preoperative Patient Characteristics and Flow Rate on Failure, Early Complications, and Voiding Dysfunction After a Transobturator Tape Procedure: A Multicentre Study.
Andrea COCCI ; Giovanni E CACCIAMANI ; Giorgio Ivan RUSSO ; Maria Angela CERRUTO ; Martina MILANESI ; Luis G MEDINA ; Sebastiano CIMINO ; Walter ARTIBANI ; Giuseppe MORGIA ; Marco CARINI ; Vincenzo LI MARZI
International Neurourology Journal 2017;21(4):282-288
PURPOSE: To evaluate the impact of preoperative patient characteristics and flow rate on failure, early postoperative complications, and voiding in patients who underwent transvaginal tension-free vaginal tape-obturator (TVT-O) treatment for uncomplicated stress urinary incontinence (SUI). METHODS: We retrospectively reviewed patients who underwent TVT-O for SUI at 3 Italian centres. The exclusion criteria were predominant voiding and storage symptoms suggestive of detrusor overactivity, the presence of grade >1 urogenital prolapse, previous pelvic radiotherapy or other clinical contraindications for surgical procedures, neurogenic bladder dysfunction, and collagen diseases. Multivariate logistic regression models were constructed to identify predictors of early voiding dysfunction after TVT-O. RESULTS: A total of 219 patients underwent TVT-O between January 2010 and December 2015. All patients received follow-up at 3, 6, and 12 months, and underwent a stress test, uroflowmetry, and bladder ultrasound to evaluate the postvoid residual volume. They also responded to the Urogenital Distress Inventory (UDI-6) questionnaire. The rates of persistent incontinence after TVT-O, postoperative complications, and satisfaction were 16.4% (36 of 219), 24.2% (53 of 219), and 86.3% (189 of 219), respectively. Nineteen patients (9.5%) experienced early voiding dysfunction. Based on an analysis of baseline characteristics, we determined that a cutoff value of 9.0 on the UDI-6 predicted postoperative SUI with 62% specificity, 72% sensitivity, and 66% accuracy. In the multivariate logistic regression analysis, a preoperative UDI-6≥9.0 was an independent predictor of postoperative SUI. The predictors of complications were menopause (P = 0.04) and the preoperative UDI-6 score (P = 0.01). CONCLUSIONS: Menopause and UDI-6 scores could be prognostic factors for persistent SUI after TVT-O. Well-designed prospective studies with a suitable number of patients are needed to corroborate our findings.
Collagen Diseases
;
Exercise Test
;
Female
;
Follow-Up Studies
;
Humans
;
Logistic Models
;
Menopause
;
Pelvic Organ Prolapse
;
Postoperative Complications
;
Prospective Studies
;
Radiotherapy
;
Residual Volume
;
Retrospective Studies
;
Sensitivity and Specificity
;
Suburethral Slings*
;
Ultrasonography
;
Urinary Bladder
;
Urinary Bladder, Neurogenic
;
Urinary Incontinence
;
Urinary Incontinence, Stress
;
Urodynamics
2.Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction.
Eugenia FRAGALA ; Giorgio Ivan RUSSO ; Alessandro DI ROSA ; Raimondo GIARDINA ; Salvatore PRIVITERA ; Vincenzo FAVILLA ; Francesco PATTI ; Blayne WELK ; Sebastiano CIMINO ; Tommaso CASTELLI ; Giuseppe MORGIA
International Neurourology Journal 2015;19(4):272-277
PURPOSE: To determine the relationship between the neurogenic bladder symptoms score (NBSS) and urodynamic examination in patients affected by multiple sclerosis (MS) and related lower urinary tract dysfunction (LUTD). METHODS: We recruited 122 consecutive patients with MS in remission and LUTD from January 2011 to September 2013 who underwent their first urodynamic examination. Neurological impairment was assessed using the Expanded Disability Status Scale (EDSS) and bladder symptoms were studied with the NBSS. RESULTS: Median NBSS was 20.0 (interquartile range, 12.75-31.0). Neurogenic detrusor overactivity (NDO) was discovered in 69 patients (56.6%). The concordance between patients with NDO and maximum detrusor pressure during involuntary detrusor contraction (PdetmaxIDC)> or =20.0 cm H2O was 0.89 (kappa-Cohen; P<0.05). Patients with EDSS scores of > or =4.5 had a greater NBSS (25.41 vs. 20.19, P<0.05), NBSS-incontinence (8.73 vs. 4.71, P<0.05), NBSS-consequence (4.51 vs. 3.13, P<0.05) and NBSS-quality of life (2.14 vs. 1.65, P<0.05). The NBSS was not associated with PdetmaxIDC> or =20 cm H2O (P=0.77) but with maximum cystometric capacity<212 mL (odds ratio, 0.95; P<0.05). CONCLUSIONS: The NBSS cannot give adequate information the way urodynamic studies can, in patients with MS and LUTD.
Humans
;
Multiple Sclerosis*
;
Urinary Bladder
;
Urinary Bladder, Neurogenic*
;
Urinary Bladder, Overactive
;
Urinary Tract*
;
Urodynamics*
3.Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study
Marina DI MAURO ; Giorgio Ivan RUSSO ; Pier Andrea DELLA CAMERA ; Fabrizio DI MAIDA ; Gianmartin CITO ; Nicola MONDAINI ; Marco CAPECE ; Marco FALCONE ; Francesco SESSA ; Andrea MARI ; Riccardo CAMPI ; Carlotta SABINI ; Sergio SERNI ; Mauro GACCI ; Andrea MINERVINI ; Marco CARINI ; Sebastiano CIMINO ; Girolamo MORELLI ; Andrea COCCI
The World Journal of Men's Health 2019;37(3):339-346
PURPOSE: In this study, we aimed to determine the role of extracorporeal shockwave therapy (ESWT) in the management of Peyronie's disease (PD). MATERIALS AND METHODS: A total of 325 patients suffering from PD were enrolled in this single-arm clinical study. All patients were received ESWT using a schedule of 1 treatment/wk. Penile curvature was measured by a goniometer after intracavernosal drug-induced erection using Alprostadil. Plaque size was measured with a ruler and sexual function assessed by the international index of erectile function (IIEF)-15 score. Severity of erectile dysfunction was classified as severe (IIEF-15 ≤10), moderate (IIEF-15 between 11 and 16), or mild (IIEF-15 between 17 and 25). Results were evaluated at baseline and 3 months after the treatment. RESULTS: All the patients completed the study protocol. Median age was 59.0 years (55.0–64.0 years). After treatment, the median (interquartile range, IQR) plaque size reduced from 1.78 cm2 (1.43–2.17 cm2) to 1.53 cm2 (1.31–1.96 cm2) (p<0.001); the median (IQR) penile length in erection increased from 13.0 cm (12.0–14.0 cm) to 14 cm (13.0–15.0 cm) (p<0.001) and the median (IQR) penile curvature from 30.4° (22.2°–35.4°) to 25.0° (20.2°–30.4°) (p<0.001). We also observed a decrease in pain assessed by visual analogue scale (7 vs. 3; p<0.001), an improvement in each of the IIEF sub-domains (p<0.001) and an improvement in all three PD questionnaire domains (p<0.001). CONCLUSIONS: Based on our findings, ESWT could be considered a safe and efficient minimally invasive option for the management of the patients suffering from PD.
Alprostadil
;
Appointments and Schedules
;
Clinical Study
;
Erectile Dysfunction
;
Humans
;
Male
;
Observational Study
;
Penile Diseases
;
Penile Induration
;
Shock
;
Treatment Outcome